Novel neutralizing SARS-CoV-2-specific mAbs offer detection of RBD linear epitopes

To stop the spread of the COVID-19 disease, it is crucial to create molecular tools to investigate and diagnose COVID-19. Current efforts focus on developing specific neutralizing monoclonal antibodies (NmAbs)...

Source: Virology Journal - February 6, 2024 Category: Virology Authors: Seyed Mostafa Mostafavi Zadeh, Ali Ahmad Bayat, Hosein Shahsavarani, Feridoun Karimi-Busheri, Jafar Kiani, Roya Ghods and Zahra Madjd Tags: Research Source Type: research